These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 30962505
1. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer. Ma C, Olevian D, Miller C, Herbst C, Jayachandran P, Kozak MM, Chang DT, Pai RK. Mod Pathol; 2019 Jul; 32(8):1217-1231. PubMed ID: 30962505 [Abstract] [Full Text] [Related]
2. Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation. Ma C, Olevian DC, Lowenthal BM, Jayachandran P, Kozak MM, Chang DT, Pai RK. Am J Surg Pathol; 2018 Oct; 42(10):1409-1417. PubMed ID: 30001238 [Abstract] [Full Text] [Related]
4. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR. Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506 [Abstract] [Full Text] [Related]
5. Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer. Li J, Zeng Q, Lin J, Huang H, Chen L. Med Mol Morphol; 2024 Mar; 57(1):1-10. PubMed ID: 37583001 [Abstract] [Full Text] [Related]
6. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials. Sinicrope FA, Shi Q, Allegra CJ, Smyrk TC, Thibodeau SN, Goldberg RM, Meyers JP, Pogue-Geile KL, Yothers G, Sargent DJ, Alberts SR. JAMA Oncol; 2017 Apr 01; 3(4):472-480. PubMed ID: 28006055 [Abstract] [Full Text] [Related]
7. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. Korphaisarn K, Pongpaibul A, Limwongse C, Roothumnong E, Klaisuban W, Nimmannit A, Jinawath A, Akewanlop C. World J Gastroenterol; 2015 Jan 21; 21(3):926-34. PubMed ID: 25624727 [Abstract] [Full Text] [Related]
8. Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers. Lee JA, Park HE, Jin HY, Jin L, Cho NY, Bae JM, Kim JH, Kang GH. Ann Diagn Pathol; 2024 Aug 21; 71():152289. PubMed ID: 38555678 [Abstract] [Full Text] [Related]
9. Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer. Hestetun KE, Aasebø K, Rosenlund NB, Müller Y, Dahl O, Myklebust MP. Mod Pathol; 2021 Jan 21; 34(1):161-170. PubMed ID: 32737450 [Abstract] [Full Text] [Related]
10. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Chang DT, Pai RK, Rybicki LA, Dimaio MA, Limaye M, Jayachandran P, Koong AC, Kunz PA, Fisher GA, Ford JM, Welton M, Shelton A, Ma L, Arber DA, Pai RK. Mod Pathol; 2012 Aug 21; 25(8):1128-39. PubMed ID: 22481281 [Abstract] [Full Text] [Related]
11. Automated Quantitation of CD8-positive T Cells Predicts Prognosis in Colonic Adenocarcinoma With Mucinous, Signet Ring Cell, or Medullary Differentiation Independent of Mismatch Repair Protein Status. Hartman DJ, Frank M, Seigh L, Choudry H, Pingpank J, Holtzman M, Bartlett D, Bahary N, Pantanowitz L, Pai RK. Am J Surg Pathol; 2020 Jul 21; 44(7):991-1001. PubMed ID: 32205483 [Abstract] [Full Text] [Related]
12. SATB2 Is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract. Ma C, Lowenthal BM, Pai RK. Am J Surg Pathol; 2018 Dec 21; 42(12):1715-1722. PubMed ID: 30212392 [Abstract] [Full Text] [Related]
13. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. Am J Surg Pathol; 2016 Mar 21; 40(3):419-32. PubMed ID: 26551622 [Abstract] [Full Text] [Related]
14. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. Ye JX, Liu Y, Qin Y, Zhong HH, Yi WN, Shi XY. World J Gastroenterol; 2015 Feb 07; 21(5):1595-605. PubMed ID: 25663779 [Abstract] [Full Text] [Related]
15. The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer. Neumann J, Heinemann V, Engel J, Kirchner T, Stintzing S. Virchows Arch; 2018 Aug 07; 473(2):199-207. PubMed ID: 29675807 [Abstract] [Full Text] [Related]
16. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H, Galván JA, Helbling M, Muller DE, Karamitopoulou E, Koelzer VH, Economou M, Hammer C, Lugli A, Zlobec I. Int J Cancer; 2014 May 15; 134(10):2342-51. PubMed ID: 24166180 [Abstract] [Full Text] [Related]
17. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Lugli A, Tzankov A, Zlobec I, Terracciano LM. Mod Pathol; 2008 Nov 15; 21(11):1403-12. PubMed ID: 18587323 [Abstract] [Full Text] [Related]
18. Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, and Synaptophysin. Yang C, Sun L, Zhang L, Zhou L, Zhao M, Peng Y, Niu D, Li Z, Huang X, Kang Q, Jia L, Lai J, Cao D. Am J Surg Pathol; 2018 Feb 15; 42(2):160-171. PubMed ID: 28914716 [Abstract] [Full Text] [Related]
19. Use of SATB2 and CDX2 Immunohistochemistry to Characterize and Diagnose Colorectal Cancer. Kato S, Koshino A, Lasota J, Komura M, Wang C, Ebi M, Ogasawara N, Kojima K, Tsuzuki T, Kasai K, Takahashi S, Miettinen M, Kasugai K, Inaguma S. Appl Immunohistochem Mol Morphol; 2024 Sep 01; 32(8):362-370. PubMed ID: 39076030 [Abstract] [Full Text] [Related]
20. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract. Giannico GA, Gown AM, Epstein JI, Revetta F, Bishop JA. Hum Pathol; 2017 Sep 01; 67():152-159. PubMed ID: 28711650 [Abstract] [Full Text] [Related] Page: [Next] [New Search]